Clinical Trial Update: Overactive Bladder Innovative Therapy Trial (OrBIT) [Phase 4]

View source ↗

Summary

A Phase 4 trial update for the Overactive Bladder Innovative Therapy Trial (OrBIT) sponsored by Uroplasty, Inc. reports completion and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Uroplasty, Inc | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2013-05-16